Bexagliflozin,
UNII-EY00JF42FV,
EGT-1442,
1118567-05-7,
Bexagliflozin [USAN],
THR-1442,
EY00JF42FV,
CHEMBL1808388,
Bexagliflozin (USAN),
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-D-glucitol,
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(2-cyclopropoxyethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol,
D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-, (1S)-,
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-, (1S)-,
EGT0001442,
EGT1442; Bexagliflozin,
egt-1474,
SCHEMBL302200,
BTCRKOKVYTVOLU-SJSRKZJXSA-N,
EX-A2332,
BDBM50349249,
ZINC59047505,
AKOS030526255,
Bexagliflozin(THR1442 EGT1442)|,
CS-5702,
DB12236,
RL00473,
SB16863,
EGT-0001442,
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol,
HY-17604,
D10865,
J-500393,
EGT1442,
A10155,